Lindus Health and Sooma Medical are partnering on the development of a medical device to treat MDD.
March 11, 2025
2
mins read
Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD
Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds
5/16/24
3
mins
We're excited to share the positive results from our study with Myota in reducing risk of developing Type 2 diabetes.
Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health’s Advisory Board
5/8/24
Welcoming our newest advisor - Dr. Tim Garnett, former CMO at Eli Lilly!
Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation
5/9/24
4
This collaboration with University of Oxford explores the perceptions of incentives and barriers to clinical trial participation among both researchers and various underrepresented groups.
Lindus Health Debuts “All-in-One Diagnostics CRO” Solution for Diagnostic Clinical Trials
4/25/24
Introducing our bespoke offering to the diagnostics market segment.
Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials
4/2/24
Introducing our "All-in-One Respiratory CRO", enabling respiratory sponsors to run more efficient and patient-centric clinical trials.
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
3/19/24
Lindus Health aims to enhance the efficiency and success rates of CNS, neurology and psychiatric clinical trials with its "All-in-One CRO" offering to this market segment.